{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:12:12Z","timestamp":1792649532255,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamaneurol.2020.1840","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T11:32:14Z","timestamp":1592825534000},"page":"1099","source":"Crossref","is-referenced-by-count":377,"title":["Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia"],"prefix":"10.1001","volume":"77","author":[{"given":"Suzanne","family":"Craft","sequence":"first","affiliation":[{"name":"Department of Internal Medicine\u2013Geriatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema","family":"Raman","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany W.","family":"Chow","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Rafii","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Kai","family":"Sun","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rissman","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"},{"name":"Department of Neurosciences, University of California, San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Donohue","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Brewer","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"},{"name":"Department of Neurosciences, University of California, San Diego, La Jolla"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecily","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Harless","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Gessert","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Aisen","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"noi200040r1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1523\/JNEUROSCI.4082-13.2014","article-title":"GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex.","volume":"34","author":"Molnar","year":"2014","journal-title":"J Neurosci"},{"issue":"3","key":"noi200040r2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"Pt B","key":"noi200040r3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.12.001","article-title":"Insulin-mediated synaptic plasticity in the CNS: anatomical, functional and temporal contexts.","volume":"136","author":"Ferrario","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"noi200040r4","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer\u2019s-linked toxins: insulin signaling prevents the pathogenic binding of abeta oligomers.","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"noi200040r5","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1091\/mbc.e17-06-0416","article-title":"Neuroprotective astrocyte-derived insulin\/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound A\u00df oligomers.","volume":"28","author":"Pitt","year":"2017","journal-title":"Mol Biol Cell"},{"issue":"1","key":"noi200040r6","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1038\/s41598-019-44635-z","article-title":"Chronic synaptic insulin resistance after traumatic brain injury abolishes insulin protection from amyloid beta and tau oligomer-induced synaptic dysfunction.","volume":"9","author":"Franklin","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"noi200040r7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","article-title":"SREBPs in lipid metabolism, insulin signaling, and beyond.","volume":"43","author":"DeBose-Boyd","year":"2018","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"noi200040r8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3233\/JAD-180906","article-title":"Early-stage Alzheimer\u2019s disease is associated with simultaneous systemic and central nervous system dysregulation of insulin-linked metabolic pathways.","volume":"68","author":"de la Monte","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"noi200040r9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3233\/JAD-2010-100795","article-title":"Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer\u2019s disease.","volume":"22","author":"Gil-Bea","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"noi200040r10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies.","volume":"128","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"noi200040r11","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1038\/s41598-017-09577-4","article-title":"Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults.","volume":"7","author":"Laws","year":"2017","journal-title":"Sci Rep"},{"issue":"13","key":"noi200040r12","doi-asserted-by":"publisher","first-page":"e1150","DOI":"10.1212\/WNL.0000000000005214","article-title":"Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation.","volume":"90","author":"Ekblad","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"noi200040r13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults.","volume":"11","author":"Willette","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"9","key":"noi200040r14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.","volume":"70","author":"Thambisetty","year":"2013","journal-title":"JAMA Neurol"},{"issue":"1","key":"noi200040r15","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","article-title":"Distribution of insulin in trigeminal nerve and brain after intranasal administration.","volume":"9","author":"Lochhead","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"noi200040r16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"noi200040r17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"issue":"7","key":"noi200040r18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrneurol.2012.112","article-title":"Alzheimer disease: insulin resistance and AD\u2014extending the translational path.","volume":"8","author":"Craft","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"noi200040r20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3233\/JAD-122308","article-title":"Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer\u2019s disease.","volume":"35","author":"Claxton","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"noi200040r21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: a pilot clinical trial.","volume":"57","author":"Craft","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"noi200040r22","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease.","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"noi200040r23","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer\u2019s Disease Assessment Scale that broaden its scope. the Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"noi200040r24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/WAD.0b013e3181cfc78b","article-title":"Free and cued selective reminding identifies very mild dementia in primary care.","volume":"24","author":"Grober","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"noi200040r25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/01688639208402827","article-title":"Glucose and memory in mild senile dementia of the Alzheimer type.","volume":"14","author":"Craft","year":"1992","journal-title":"J Clin Exp Neuropsychol"},{"issue":"5","key":"noi200040r26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1006\/nimg.2001.0756","article-title":"Qualitative and quantitative evaluation of six algorithms for correcting intensity nonuniformity effects.","volume":"13","author":"Arnold","year":"2001","journal-title":"Neuroimage"},{"issue":"2","key":"noi200040r27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.neuroimage.2005.09.046","article-title":"Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data.","volume":"30","author":"Jovicich","year":"2006","journal-title":"Neuroimage"},{"issue":"1","key":"noi200040r28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data.","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans Med Imaging"},{"issue":"7","key":"noi200040r29","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/dom.2018.20.issue-7","article-title":"Safety of intranasal human insulin: a review.","volume":"20","author":"Schmid","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"noi200040r30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3233\/JAD-180548","article-title":"Clinical experience with cerebrospinal fluid A\u00df42, total and phosphorylated tau in the evaluation of 1,016 individuals for suspected dementia.","volume":"65","author":"Tariciotti","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"noi200040r31","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3233\/JAD-170511","article-title":"Alzheimer\u2019s disease biomarkers and future decline in cognitive normal older adults.","volume":"60","author":"Dumurgier","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"noi200040r32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","article-title":"CSF A\u00df42\/A\u00df40 and A\u00df42\/A\u00df38 ratios: better diagnostic markers of Alzheimer disease.","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"noi200040r19","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6 (R1). June 10, 1996. https:\/\/ichgcp.net\/"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2767376\/jamaneurology_craft_2020_oi_200040_1598965184.79141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T04:33:53Z","timestamp":1616301233000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2767376"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.1840","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}